Experimental cancer drug trial halted early
Disease control
Terminated
This study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer that had stopped responding to hormone therapy, as well as other solid tumors. The trial aimed to see if the drug could slow cancer growth and shrink tumors. The study …
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC